Radcliffe Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-25,130
| Closed | -$249K | – | 1218 |
|
|
2021
Q4 | $249K | Sell |
25,130
-1
| -0% | -$10 | 0.01% | 1009 |
|
|
2021
Q3 | $248K | Hold |
25,131
| – | – | 0.01% | 859 |
|
|
2021
Q2 | $260K | Buy |
25,131
+5,131
| +26% | +$53.1K | 0.01% | 884 |
|
|
2021
Q1 | $205K | Hold |
20,000
| – | – | 0.01% | 673 |
|
|
2020
Q4 | $227K | Buy |
+20,000
| New | +$227K | 0.01% | 228 |
|